Self.co

📍 Riešės k., Lithuania👥 13 employees💰 Last funded Aug 2025
Self.co helps people uncover the real causes of their allergy-like symptoms through smart, science-based tests and insights. Self.co was created to help people finally understand what’s really behind their allergy-like symptoms. Today, up to half of all people believe they have an allergy, yet many never find clear answers because testing is complicated, expensive, or simply out of reach. With Self.co, you can easily take science-based tests from home and get clear, personalized results that show what’s truly affecting your wellbeing — all at an affordable price. As a health tech company, we develop our own testing technology to make results more accurate, accessible, and insightful. So far, nearly 30,000 people have already trusted Self.co to uncover the real causes of their symptoms and feel better in their everyday lives.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Lithuania
1
Frequently asked questions
Who invested in Self.co?
Self.co has 1 investors on record on gritt.io.
When did Self.co last raise funding?
The most recent investment in Self.co recorded on gritt.io was in August 2025.
What industry is Self.co in?
Self.co operates in Home Health Care Services. Find similar Home Health Care Services investors on gritt.io.
Where is Self.co based?
Self.co is headquartered in Riešės k., Lithuania.